Technical analysis of ICU Medical, Inc. (ICUI): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps.
Price Performance
| 1 month | +1.80% |
| 3 months | -1.26% |
| Year-to-date | +16.63% |
| 1 year | +41.40% |
| 3 years | +69.04% |
| 5 years | -28.93% |
| 10 years | +19.45% |
52-Week Range
| 52-week High | $192.85 |
| 52-week Low | $113.37 |
| Avg Volume (90d) | 276K |
Technical Indicators
| SMA 50 | $164.97 |
| SMA 200 | $148.42 |
| Beta | 0.85 |
| 30-day Volatility (annualised) | 28.2% |
| Price vs SMA 50 | +0.9% |
| Price vs SMA 200 | +12.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $142.67 | |
| 2026-01 | $149.90 | +5.1% |
| 2026-02 | $150.58 | +0.5% |
| 2026-03 | $129.15 | -14.2% |
| 2026-04 | $119.20 | -7.7% |
| 2026-05 | $135.39 | +13.6% |
| 2026-06 | $146.60 | +8.3% |
| 2026-07 | $168.51 | +14.9% |
| 2026-07 | $168.51 | +0.0% |
| 2026-08 | $172.95 | +2.6% |
| 2026-09 | $160.51 | -7.2% |
| 2026-10 | $166.39 | +3.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-05 | $2.14 | $552M |
| 2026-08-06 | $1.91 | $533M |
| 2026-05-07 | $1.78 | $521M |
| 2026-02-19 | $1.68 | $531M |
| 2025-11-06 | $1.43 | $511M |
| 2025-08-07 | $1.44 | $511M |
| 2025-05-08 | $1.23 | $604M |
Price
| Price | $166.39 (closing price, October 28, 2026) |
| Market Cap | $4.2B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 141.01 |
| Price / Book | 1.89 |
| EV / EBITDA | 20.41 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.59 |
| Current Ratio | 2.43 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 2.17 |